Biotechnology

New approaches in alternative energy sources and food production, fermentation processes, modified enzymes for processing technologies – PROvendis offers various biotechnologies for licensing, to purchase or for development cooperation.

Don't hesitate to contact us! You can also find further contact persons in each technology offer.

 

Contact:

Dr. Andreas Wagener

aw@provendis.info
+49 208 9410538

Protective cover made of yeast

Yeast cells are a by-product of beer and bioethanol production and are therefore readily available.

Cyclic AMP Biosensor

Cyclic AMP is a key molecule in 2nd messenger cell signalling. Great effort has been taken to develop sensors that allow for noninvasive assessment of cAMP concentrations in living cells.

Enantiomerically pure chiral N-acyl-a-aminonitriles

Enantiomerically pure N-acyl-a-aminonitriles gained these days interest in the pharmaceutical industry since a range of recently developed pharmaceuticals are based on this product class.

Food Quality Control

Food with high sugar content is prone to contamination with yeasts that have a high osmotic tolerance. This contamination leads to a shortened storage life and a loss of quality.

C4 plant selective herbicide

Weed infestations cause considerable crop yield losses worldwide. C4 weeds like Black-Grass, Cleavers, Green foxtail, Kochia and Barnyard Grass reduce yields of important C3 cereals such as rice, wheat, barley and oat.

Submerged Bioprinting

The present invention allows to print the conduits submerged in non-miscible solvents of high density, such as fluorocarbons (e.g. C12F27N), that support the printed structure while it is being generated resulting in superior performance in relation to other methods. Viable cells 24 h after the printing process, as well as after 21 days in culture.

3D-TAM (Tumour Angiogenesis Model)

This model can be used to analyse tumour groth, tumour angiogenesis and therapeutic effects on the 3D-printed cell model. No animal tissue is needed. Therefore, this 3D-printed Tumour Model represents an ideal in-vitro-prescreening system for testing pharmaceuticals and diagnostics and might be able to circumvent or at least reduce the number of animal tests in drug development.

New Cryptophycins for ADC and SMDC

The present invention combines new synthetic ways to new Cryptophycin derivatives with alternative conjugation possibilites and pico-molar cytotoxicies, for ADC and SMDC synthesis.

High-Redshift BODIPY Dyes

Fluorescent molecules are widely used in bioimaging and medicinal applications for several decades due to their high sensitivity and easy visibility.

Plasma Biocatalysis

Enzymatic reactions offer the possibility to synthesize new molecules with high selectivity and turnover.

Split Inteins Without Active Site Cysteine

Inteins are protein domains that auto-catalyze protein-splicing of their flanking regions with a peptide bond.